Tomas Riman

Summary

Affiliation: Falun Hospital
Country: Sweden

Publications

  1. ncbi Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women
    Tomas Riman
    Department of Obstetrics and Gynecology, Falu Hospital, Falun, Sweden
    J Natl Cancer Inst 94:497-504. 2002
  2. ncbi Risk factors for invasive epithelial ovarian cancer: results from a Swedish case-control study
    Tomas Riman
    Department of Obstetrics and Gynecology, Falu Hospital, Falun, Sweden
    Am J Epidemiol 156:363-73. 2002
  3. ncbi Some life-style factors and the risk of invasive epithelial ovarian cancer in Swedish women
    Tomas Riman
    Department of Obstetrics and Gynecology, Falu Hospital, Falun, Sweden
    Eur J Epidemiol 19:1011-9. 2004
  4. ncbi Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies
    Tomas Riman
    Department of Obstetrics and Gynecology, Falu Hospital, Falun, Sweden
    Acta Obstet Gynecol Scand 83:783-95. 2004
  5. ncbi Hormone replacement therapy and epithelial ovarian cancer: is there and association?
    Tomas Riman
    Consultant in Obstetrics and Gynaecology, Department of Obstetrics and Gynaecology, Falu Hospital, Falun, and Center for Clinical Research, Dalarna, Sweden
    J Br Menopause Soc 9:61-8. 2003
  6. ncbi Hormone replacement therapy and ovarian cancer risk--any news?
    Tomas Riman
    Department of Obstetrics and Gynecology, Falu Hospital, Falun, Sweden
    Acta Obstet Gynecol Scand 86:1032-4. 2007
  7. ncbi Gender of offspring and maternal risk of invasive epithelial ovarian cancer
    Inkyung Baik
    Division of Biostatistics and Epidemiology, Cancer Center, University of Massachusetts Medical School, Worcester, Massachusetts 01605, USA
    Cancer Epidemiol Biomarkers Prev 16:2314-20. 2007
  8. ncbi A prospective study of the transient decrease in ovarian cancer risk following childbirth
    Qin Liu
    Division of Biostatistics and Epidemiology, University of Massachusetts Cancer Center, 364 Plantation Street, LRB 427, Worcester, MA 01605, USA
    Cancer Epidemiol Biomarkers Prev 15:2508-13. 2006
  9. ncbi Use of hormone replacement therapy before and after ovarian cancer diagnosis and ovarian cancer survival
    Chantal Mascarenhas
    Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden
    Int J Cancer 119:2907-15. 2006
  10. ncbi Predictors of ovarian cancer survival: a population-based prospective study in Sweden
    Ling Yang
    Clinical Trial Service Unit, University of Oxford, Oxford, United Kingdom
    Int J Cancer 123:672-9. 2008

Collaborators

Detail Information

Publications11

  1. ncbi Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women
    Tomas Riman
    Department of Obstetrics and Gynecology, Falu Hospital, Falun, Sweden
    J Natl Cancer Inst 94:497-504. 2002
    ..This nationwide case-control study examined EOC risk in relation to HRT regimens with sequentially added progestins (HRTsp) and continuously added progestins (HRTcp)...
  2. ncbi Risk factors for invasive epithelial ovarian cancer: results from a Swedish case-control study
    Tomas Riman
    Department of Obstetrics and Gynecology, Falu Hospital, Falun, Sweden
    Am J Epidemiol 156:363-73. 2002
    ..Ever use of hormone replacement therapy increased EOC risk (odds ratio = 1.41, 95% CI: 1.15, 1.72). Among etiologic hypotheses, the retrograde transportation hypothesis accommodates most epidemiologic findings concerning EOC risk...
  3. ncbi Some life-style factors and the risk of invasive epithelial ovarian cancer in Swedish women
    Tomas Riman
    Department of Obstetrics and Gynecology, Falu Hospital, Falun, Sweden
    Eur J Epidemiol 19:1011-9. 2004
    ..The use of coffee, alcohol, or cigarette smoking does not appear to increase the risk of EOC...
  4. ncbi Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies
    Tomas Riman
    Department of Obstetrics and Gynecology, Falu Hospital, Falun, Sweden
    Acta Obstet Gynecol Scand 83:783-95. 2004
    ..The aim of this review is to summarize the epidemiological findings on reproductive factors and ovarian cancer risk. These findings are considered in the context of etiologic hypotheses and some new research areas are suggested...
  5. ncbi Hormone replacement therapy and epithelial ovarian cancer: is there and association?
    Tomas Riman
    Consultant in Obstetrics and Gynaecology, Department of Obstetrics and Gynaecology, Falu Hospital, Falun, and Center for Clinical Research, Dalarna, Sweden
    J Br Menopause Soc 9:61-8. 2003
    ..Further, the findings regarding HRT and EOC risk will be discussed in the context of available aetiological hypotheses. Finally, any clinical implications are commented upon...
  6. ncbi Hormone replacement therapy and ovarian cancer risk--any news?
    Tomas Riman
    Department of Obstetrics and Gynecology, Falu Hospital, Falun, Sweden
    Acta Obstet Gynecol Scand 86:1032-4. 2007
  7. ncbi Gender of offspring and maternal risk of invasive epithelial ovarian cancer
    Inkyung Baik
    Division of Biostatistics and Epidemiology, Cancer Center, University of Massachusetts Medical School, Worcester, Massachusetts 01605, USA
    Cancer Epidemiol Biomarkers Prev 16:2314-20. 2007
    ..Our findings suggest that hormonal and physiologic conditions in pregnancy with male, but not with female, offspring are associated with a lowered maternal risk of invasive epithelial ovarian cancer...
  8. ncbi A prospective study of the transient decrease in ovarian cancer risk following childbirth
    Qin Liu
    Division of Biostatistics and Epidemiology, University of Massachusetts Cancer Center, 364 Plantation Street, LRB 427, Worcester, MA 01605, USA
    Cancer Epidemiol Biomarkers Prev 15:2508-13. 2006
    ..The period before the risk increases again could indicate the period required for ovarian cancer induction...
  9. ncbi Use of hormone replacement therapy before and after ovarian cancer diagnosis and ovarian cancer survival
    Chantal Mascarenhas
    Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden
    Int J Cancer 119:2907-15. 2006
    ..Women using HRT after diagnosis had a better survival than women with no use, but we cannot rule out that this latter finding may reflect a subtle selection process...
  10. ncbi Predictors of ovarian cancer survival: a population-based prospective study in Sweden
    Ling Yang
    Clinical Trial Service Unit, University of Oxford, Oxford, United Kingdom
    Int J Cancer 123:672-9. 2008
    ....
  11. ncbi Gestational age and fetal growth in relation to maternal ovarian cancer risk in a Swedish cohort
    Lorelei A Mucci
    Channing Laboratory, Harvard Medical School Brigham and Women s Hospital, 181 Longwood Avenue, 3rd Floor, Boston, MA 02115, USA
    Cancer Epidemiol Biomarkers Prev 16:1828-32. 2007
    ..Pregnancy influences subsequent maternal ovarian cancer risk. To date, there is limited evidence whether two characteristics of pregnancy, gestational age and birth weight, could modify risk...